- Jeffrey L. Carson, MD;
- Brenda J. Grossman, MD, MPH;
- Steven Kleinman, MD;
- Alan T. Tinmouth, MD;
- Marisa B. Marques, MD;
- Mark K. Fung, MD, PhD;
- John B. Holcomb, MD;
- Orieji Illoh, MD;
- Lewis J. Kaplan, MD;
- Louis M. Katz, MD;
- Sunil V. Rao, MD;
- John D. Roback, MD, PhD;
- Aryeh Shander, MD;
- Aaron A.R. Tobian, MD, PhD;
- Robert Weinstein, MD;
- Lisa Grace Swinton McLaughlin, MD; and
- Benjamin Djulbegovic, MD, PhD,
- for the Clinical Transfusion Medicine Committee of the AABB*
+ Author Affiliations
Abstract
Description: Although
approximately 85 million units of red blood cells (RBCs) are transfused
annually worldwide, transfusion practices
vary widely. The AABB (formerly, the American
Association of Blood Banks) developed this guideline to provide clinical
recommendations
about hemoglobin concentration thresholds and
other clinical variables that trigger RBC transfusions in
hemodynamically stable
adults and children.
Methods: These
guidelines are based on a systematic review of the literature on
randomized clinical trials evaluating transfusion
thresholds. We performed a literature search
from 1950 to February 2011 with no language restrictions. We examined
the proportion
of patients who received any RBC transfusion and
the number of RBC units transfused to describe the effect of
restrictive
transfusion strategies on RBC use. To determine
the clinical consequences of restrictive transfusion strategies, we
examined
overall mortality, nonfatal myocardial
infarction, cardiac events, pulmonary edema, stroke, thromboembolism,
renal failure,
infection, hemorrhage, mental confusion,
functional recovery, and length of hospital stay.
Recommendation 1: The AABB recommends adhering to a restrictive transfusion strategy (7 to 8 g/dL) in hospitalized, stable patients (Grade:
strong recommendation; high-quality evidence).
Recommendation 2: The
AABB suggests adhering to a restrictive strategy in hospitalized
patients with preexisting cardiovascular disease and
considering transfusion for patients with
symptoms or a hemoglobin level of 8 g/dL or less (Grade: weak
recommendation; moderate-quality
evidence).
Recommendation 3: The
AABB cannot recommend for or against a liberal or restrictive
transfusion threshold for hospitalized, hemodynamically
stable patients with the acute coronary syndrome
(Grade: uncertain recommendation; very low-quality evidence).
Recommendation 4: The
AABB suggests that transfusion decisions be influenced by symptoms as
well as hemoglobin concentration (Grade: weak recommendation;
low-quality evidence).
No comments:
Post a Comment